HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of inverse psoriasis with efalizumab.

Abstract
Various topical and systemic treatments have shown efficacy in plaque and palmoplantar psoriasis; however, studies regarding efficacy in inverse psoriasis are few. The authors present a case of a patient with severe inverse psoriasis who was successfully treated with efalizumab, resulting in complete and sustained remission during prolonged maintenance therapy.
AuthorsDornechia George, Ted Rosen
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 8 Issue 1 Pg. 74-6 (Jan 2009) ISSN: 1545-9616 [Print] United States
PMID19180901 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • efalizumab
Topics
  • Aged
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents (administration & dosage, therapeutic use)
  • Humans
  • Injections, Subcutaneous
  • Male
  • Psoriasis (drug therapy)
  • Remission Induction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: